University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Jennifer Cocohoba

Jennifer Cocohoba, Pharm.D.

Pharmacist

Jennifer Cocohoba is a clinical pharmacist for the Women's HIV Program at UCSF Medical Center. She provides training and education to help patients better adhere to their medications. She assists staff with medication-related questions, selection of antiretrovirals and other drug therapy, and interpretation of antiretroviral resistance tests.

Cocohoba's research interests include antiretroviral pharmacoepidemiology, treatment disparities and designing interventions to increase uptake and adherence to HIV antiretrovirals.

Cocohoba earned a doctor of pharmacy degree and completed a pharmacy practice residency at UCSF, then a specialty residency in HIV/AIDS ambulatory care at San Francisco General Hospital before joining the faculty in 2003. She is currently an associate clinical professor in the Department of Clinical Pharmacy, UCSF School of Pharmacy.

Clinics

HIV/AIDS Program
400 Parnassus Ave., Fourth Floor, Room A-429
San Francisco, CA 94143
Phone: (415) 353-2119
Fax: (415) 353-2406

Hours: Monday to Thursday
8:30 a.m. – noon, 1 – 5 p.m.

Conditions & Treatments

More about Jennifer Cocohoba

Education

UCSF School of Pharmacy 2001

Residencies

UCSF Medical Center 2002

Selected Research and Publications

  1. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e67-73.
  2. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012 Sep; 26(9):526-31.
  3. Cocohoba JM, Althoff KN, Cohen M, Hu H, Cunningham CO, Sharma A, Greenblatt RM. Pharmacist counseling in a cohort of women with HIV and women at risk for HIV. Patient Prefer Adherence. 2012; 6:457-63.
  4. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322.
  5. Sherman EM, Cocohoba JM, Neff SE, Dong BJ. Health care provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians' Consultation Center. Ann Pharmacother. 2011 Dec; 45(12):1499-505.
  6. Cocohoba JM, Althoff KN, Godfrey R, Palella FJ, Greenblatt RM. Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART. AIDS Care. 2012; 24(1):20-9.
  7. Lao CK, Gruta C, John MD, Cocohoba J. A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians. J Natl Med Assoc. 2011 Jun; 103(6):518-22.
  8. Yi T, Cocohoba J, Cohen M, Anastos K, DeHovitz JA, Kono N, Hanna DB, Hessol NA. The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women. J Acquir Immune Defic Syndr. 2011 Mar; 56(3):253-62.
  9. Cocohoba J. Hormonal contraception for HIV positive women. BETA. 2010 Winter-Spring; 22(2):36-40.
  10. Cocohoba J. The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals. Expert Rev Anti Infect Ther. 2009 Dec; 7(10):1159-63.
  11. Cocohoba J, Ramay B, Patterson S. HIV postexposure prophylaxis availability in U.S. rural hospitals. Am J Health Syst Pharm. 2008 Oct 1; 65(19):1796-7.
  12. Cocohoba J, Dong BJ. Raltegravir: the first HIV integrase inhibitor. Clin Ther. 2008 Oct; 30(10):1747-65.
  13. El-Ibiary SY, Cocohoba JM. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. Eur J Contracept Reprod Health Care. 2008 Jun; 13(2):123-32.
  14. Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2008 Mar 1; 47(3):377-83.
  15. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5.
  16. El-Ibiary S, Cocohoba J. Refusals by pharmacists to dispense emerging contraception: a critique. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):692; author reply 692-3.
  17. Dong BJ, Cocohoba JM. Tipranavir: a protease inhibitor for HIV salvage therapy. Ann Pharmacother. 2006 Jul-Aug; 40(7-8):1311-21.
  18. Graves D, Cocohoba J, Gruta C, Goldschmidt R. Potential adverse effects and inferior efficacy in ARV treatment. J Natl Med Assoc. 2004 May; 96(5):692-3; author reply 693.
  19. Cocohoba JM, McNicholl IR. Valganciclovir: an advance in cytomegalovirus therapeutics. Ann Pharmacother. 2002 Jun; 36(6):1075-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California